Mission StatementConnexon Creative’s mission is to accelerate science by providing tools that enhance communication within science and medicine.
HistoryConnexon Creative began with the publication of Cell Therapy News, which was originally sent as a personal email to several colleagues in the cell therapy community as a way to communicate the field’s latest biomedical developments. The number of people interested in these emails quickly grew, as did their content, and Cell Therapy News was first published online and sent to 3,000 subscribers in February, 2002. Since then, the subscribership of Cell Therapy News, which remains Connexon’s largest and most popular newsletter, has grown to include approximately 9,000 biomedical researchers and industry professionals in science and medicine!
Recognizing that the success of Cell Therapy News signified a genuine need for an effective platform for communicating science to scientists, Connexon Creative began adding additional free science newsletters to its publication repertoire in 2007, and has since expanded its offering to 20 weekly publications covering a number of areas in cell biology and immunology. Combined, these have garnered more than 60,000 subscriptions.
A part of the STEMCELL group of companies, Connexon Creative fulfills the mandate “Scientists Helping Scientists” by providing researchers and medical professionals with expertly-prepared, timely, comprehensive updates on their fields. By saving our readers time and keeping them informed, our services allow scientists to devote more time and energy towards advancing science and medicine.
Connexon Creative’s Online Publications
|Newsletter||Release Day||Launch Year|
|Cell Therapy News||Monday||2002|
|ESC & iPSC News||Wednesday||2007|
|Neural Cell News||Wednesday||2008|
|Cord Blood News||Thursday||2009|
|Mesenchymal Cell News||Tuesday||2009|
|Mammary Cell News||Thursday||2009|
|Immune Regulation News||Friday||2009|
|Pancreatic Cell News||Tuesday||2010|
|Prostate Cell News||Friday||2010|
|Extracellular Matrix News||Thursday||2010|
|Cancer Stem Cell News||Wednesday||2012|
|Pulmonary Cell News||Thursday||2012|
|Immunology of Infectious Disease News||Wednesday||2013|
|Human Immunology News||Tuesday||2013|
|Intestinal Cell News||Friday||2015|
|Dermal Cell News||Monday||2015|
|Muscle Cell News||Monday||2016|
|Endothelial Cell News||Monday||2016|
|Hepatic Cell News||Friday||2017|
Social MediaYou can also stay engaged with the scientific and medical communities by joining Connexon Creative on Twitter and Facebook.
|Cancer Stem Cell News – @CancerSCNews|
Cell Therapy News – @CellTherapyNews
Cord Blood News – @Cord_Blood_News
Dermal Cell News – @DermalCell
Endothelial Cell News – @EndothelialNews
ESC & iPSC News – @ESC_iPSC_News
Extracellular Matrix News – @ExtracellMatrix
Hepatic Cell News – @HepaticCellNews
Hematopoiesis News – @Hema_News
Human Immunology News – @HumanImmuneNews
Immune Regulation News – @Immune_News
Immunology of Infectious Disease News – @InfDisease_News
Intestinal Cell News – @Intestinal_Cell
Mammary Cell News – @MammaryCell
Mesenchymal Cell News – @MesenchymalCell
Muscle Cell News – @MuscleCellNews
Neural Cell News – @NeuralCell
Pancreatic Cell News – @PancreaticCell
Prostate Cell News – @ProstateCell
Pulmonary Cell News – @Pulmonary_News
|Cell Therapy News|
What’s Next?Connexon Creative is not done expanding! Our subscribership continues to increase, and we have identified many more niches to cover within the exciting, constantly advancing fields of science and medicine. We are extremely passionate about science communication, and ultimately, our goal is to serve as a global information hub for medical professionals and academic and industrial researchers in the biomedical fields. Specifically, we aim to facilitate the advancement of scientific discovery and innovation by providing an effective, efficient means for science professionals to keep current with research findings and science news, as well as to support growth, connection and collaboration amongst members of the scientific and medical communities.
Visit our Subscription Center to sign-up for our weekly newsletters.